Association Between a Distinctive Autoantibody-Associated Brainstem Sensory Syndrome and Immune Checkpoint Inhibitors.

Damato, Valentina; Berretta, Antonio; Ramanathan, Sudarshini; Michael, Sophia; Coupe, Nicholas; Payne, Miranda; Irani, Sarosh R

Damato, Valentina; Berretta, Antonio; Ramanathan, Sudarshini; Michael, Sophia; Coupe, Nicholas; Payne, Miranda; Irani, Sarosh R.

Afiliación

Damato V; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Berretta A; Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, United Kingdom.
Ramanathan S; Department of Neurosciences, Drugs and Child Health, University of Florence, Florence, Italy.
Michael S; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Coupe N; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Payne M; Translational Neuroimmunology Group, Kids Neuroscience Centre, Children's Hospital at Westmead, Westmead, Australia.
Irani SR; Department of Neurology, Concord Hospital, Sydney, Australia.

JAMA Neurol ; 79(9): 949-951, 2022 09 01.

Article en En | MEDLINE | ID: mdl-35816342

Asunto(s)

Antineoplásicos Inmunológicos; Neoplasias; Antineoplásicos Inmunológicos/uso terapéutico; Autoanticuerpos; Tronco Encefálico; Humanos; Inhibidores de Puntos de Control Inmunológico; Inmunoterapia; Neoplasias/tratamiento farmacológico; Síndrome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: JAMA Neurol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google